GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro

Title
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
Authors
김홍남Kyung Soo HongJune Hong AhnJong Geol JangJong Ho LeeDongha KimWonhwa Lee
Issue Date
2020-11
Publisher
Signal Transduction and Targeted Therapy
Citation
VOL 5, 267
URI
http://pubs.kist.re.kr/handle/201004/72253
ISSN
2095-9907
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE